Comparative study of reversed-phase high-performance liquid chromatography versus thin-layer chromatography-densitometry for determination of Citicoline sodium in presence of its alkaline degradation products
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Mahmoud O.A. | |
dc.contributor.author | Hegazy M.A. | |
dc.contributor.author | Salem H. | |
dc.contributor.author | Moustafa A.A. | |
dc.contributor.other | Analytical Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | October City | |
dc.contributor.other | 11787 | |
dc.contributor.other | Egypt; Analytical Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Kasr-El Aini Street | |
dc.contributor.other | Cairo | |
dc.contributor.other | 11562 | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:58Z | |
dc.date.available | 2020-01-09T20:41:58Z | |
dc.date.issued | 2015 | |
dc.description | Scopus | |
dc.description.abstract | Simple, sensitive, selective, and precise stability-indicating thin-layer chromatography (TLC)-densitometric and reversed-phase high-performance liquid chromatography (RP-HPLC) methods were developed and validated for the determination of citicoline sodium (CT) in the presence of its alkaline degradation products (CT Deg.) and in pharmaceutical oral solution. TLC-densitometry employs aluminum TLC plates precoated with silica gel 60 F254 as the stationary phase and ammonia-ethyl acetate-triethylamine (6:3.5:0.5, v/v) as the mobile phase to give compact spots for citicoline sodium (RF = 0.35) and its degradation product (RF = 0.1); the chromatogram was scanned at 272 nm. RP-HPLC utilizes a C18 column and a mobile phase consisting of methanol-water-acetic acid (60:40:0.1, v/v); the pH level was adjusted to 4 using 0.1% orthophosphoric acid, at a flow rate of 1 mL min-1 for the separation of citicoline sodium (tR = 1.801) and its degradation product (tR = 3.422). Quantitation was achieved by ultraviolet (UV) detection at 272 nm. Citicoline sodium was exposed to alkaline hydrolysis, and a comparative study was carried out to show the advantages of the proposed chromatographic methods in determination of citicoline sodium in the presence of its alkaline degradation products. The chromatographic methods were developed and validated as per the International Conference on Harmonization guidelines. As the methods could effectively separate the drug from their degradation products, these techniques can be employed as stability-indicating methods that have been successively applied to pharmaceutical formulations without interference from the excipients. � Akad�miai Kiad�, Budapest. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=24059&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1556/1006.2015.28.3.8 | |
dc.identifier.doi | PubMed ID : | |
dc.identifier.issn | 9334173 | |
dc.identifier.other | https://doi.org/10.1556/1006.2015.28.3.8 | |
dc.identifier.other | PubMed ID : | |
dc.identifier.uri | https://t.ly/epWJn | |
dc.language.iso | English | en_US |
dc.publisher | Akademiai Kiado Rt. | en_US |
dc.relation.ispartofseries | Journal of Planar Chromatography - Modern TLC | |
dc.relation.ispartofseries | 28 | |
dc.subject | Citicoline | en_US |
dc.subject | Degradation products | en_US |
dc.subject | Reversed-phase high-performance liquid chromatography | en_US |
dc.subject | Thin-layer chromatography-densitometry | en_US |
dc.subject | Alkalinity | en_US |
dc.subject | Chromatographic analysis | en_US |
dc.subject | Computerized tomography | en_US |
dc.subject | Degradation | en_US |
dc.subject | Drug products | en_US |
dc.subject | High performance liquid chromatography | en_US |
dc.subject | Liquid chromatography | en_US |
dc.subject | Liquids | en_US |
dc.subject | Organometallics | en_US |
dc.subject | Orthophosphoric acid | en_US |
dc.subject | Silica gel | en_US |
dc.subject | Sodium | en_US |
dc.subject | Thin layer chromatography | en_US |
dc.subject | Alkaline degradation products | en_US |
dc.subject | Chromatographic methods | en_US |
dc.subject | Citicoline | en_US |
dc.subject | Degradation products | en_US |
dc.subject | International conference on harmonizations | en_US |
dc.subject | Pharmaceutical formulation | en_US |
dc.subject | Reversed phase high performance liquid chromatography | en_US |
dc.subject | Stability indicating method | en_US |
dc.subject | Chromatography | en_US |
dc.subject | acetic acid ethyl ester | en_US |
dc.subject | aluminum | en_US |
dc.subject | ammonia | en_US |
dc.subject | citicoline | en_US |
dc.subject | citicoline sodium | en_US |
dc.subject | phosphoric acid | en_US |
dc.subject | silica gel | en_US |
dc.subject | triethylamine | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | analytic method | en_US |
dc.subject | Article | en_US |
dc.subject | chemical structure | en_US |
dc.subject | comparative study | en_US |
dc.subject | controlled study | en_US |
dc.subject | degradation | en_US |
dc.subject | densitometry | en_US |
dc.subject | flow rate | en_US |
dc.subject | hydrolysis | en_US |
dc.subject | limit of detection | en_US |
dc.subject | limit of quantitation | en_US |
dc.subject | oxidation | en_US |
dc.subject | practice guideline | en_US |
dc.subject | reversed phase high performance liquid chromatography | en_US |
dc.subject | thin layer chromatography | en_US |
dc.subject | ultraviolet radiation | en_US |
dc.title | Comparative study of reversed-phase high-performance liquid chromatography versus thin-layer chromatography-densitometry for determination of Citicoline sodium in presence of its alkaline degradation products | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Donato, E., Dias, C., Rossi, R., Valente, R., Froehlich, P., Bergold, A., (2006) Chromatographia, 63, pp. 437-443; Teather, L., Wurtman, R., (2005) Learn. Mem, 12, pp. 39-43; Silveri, M., Dikan, J., Ross, A., (2008) NMR Biomed, 21, pp. 1066-1075; Parisi, V., Coppola, G., Centofanti, M., Oddone, F., Angrisani, A., Ziccardi, L., Ricci, B., Manni, G., (2008) Prog. Brain Res, 173, pp. 541-554; Patel, J.A., Panigrahi, B., Patel, C.N., Ramalingan, B., (2011) Chron. Young Sci, 2, pp. 150-154; Surani, S., Kimbahune, R., Kabra, P., Urmila, G.H., (2011) Scholars Res Libr, 2, pp. 353-357; Malipatil, S.M., Patil, S.K., Deepthi, M., Jahan, K., (2011) J. Pharm. Res, 3, pp. 785-787; Malipatil, S.M., Patil, S.K., Deepti, M., Jahan, K., (2011) Int. J. Pharm. Res. Dev. Online (IJPRD), 2, pp. 27-30; Sachan, N., Chandra, P., Yadav, M., Pal, D., Ghosh, A.K., (2011) J. Appl. Pharm. Sci, 1, pp. 191-193; Patel, J.A., Panigrahi, B., Patel, C.N., Ramalingan, B., Modh, K., (2011) J. Pharm. Res, 3, p. 2876; Goti, P., Savsani, J., Savjiyani, N., Bangoriya, U., (2012) Inventi Rapid Pharm Anal. Qual. Assur, , http://www.inventi.in/Article/ppaqa/466/12.aspx25/12/2012; Shamjibhai, S.S., (2011) Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, , http://hdl.handle.net/123456789/51706/12/2012; Prajapati, M.G., Parmar, R.R., Patel, V.M., Shah, D.A., (2012) Int. J. Inst. Pharm. Life Sci, 2, pp. 438-446; Ankit, P., Analytica Acta-2012, , http://omicsonline.org/analyticaacta2012/,6/1/2012; Prajapati, V.D., Shah, J.S., Patel, P.B., (2012) Inventi Rapid Pharm Anal. Qual. Assur, , http://www.inventi.in/Article/ppaqa/314/12.aspx2/1/2013; Kabra, P.V., Nargund, L.V.G., Murthy, M.S., (2012) Int. J. Pharm. Sci. Rev. Res, 16, pp. 111-114; Surani, S., Kabra, P., Kimbahune, R., Sunil, K., Nargund, L.V.G., (2012) Int. J. Pharm. Tech. Res, 4, pp. 1136-1141; Raga Pravallika, E., Prashanthi, D., Ismail, Y., (2012) Int. J. Chem. Pharm. Sci, 3, pp. 76-79; Uttarwa, S.O., Jadhav, R.T., Bonde, C., (2011) Int. J. Pharm. Tech. Res, 2, pp. 2482-2486; Babu, G.R., Madhu, M.S., Rao, M.P., Babu, C.A., Reddy, P.J., Nagaraju, D., (2011) Int. J. Pharm. Technol, 2, pp. 651-660; Ganduri, R.B., Peddareddigari, J.R., Dasari, N.R., Saiempu, R.K., (2011) Int. J. Pharm. Technol, 2, pp. 427-433; Liu, T., Wang, P., Zhou, H., Li, J., Qiu, X., (2011) Zhongguo Yaoshi, 14, pp. 488-490. , through chem. abst CD; Zhao, M., Gao, J., Ji, Y., Shen, J., Liu, J., Qi, B., Cheng, Y., Zhao, C., (2011) Jiefangjun Yaoxue Xuebao, 27, pp. 532-534f. , through chem. abst CD; He, W., (2011) Changchun Gongye Daxue Xuebao, 32, pp. 343-347. , through chem. abst CD; Bindaiya, S.K., Sahu, K., Bhaisare, M., Karthikeyan, C., Moorthy, N., Mehta, F.F., Trivedi, P., (2011) Lat. Am. J. Pharm, 30, pp. 794-798; Babu, G., Prasad, K., Kolla, T., Vijayabaskaran, M., Latha, S.T., (2011) Int. J. Pharm. Tech. Res, 3, pp. 1311-1313; Yang, Y., Wang, Y., Li, X., Sun, L., (2011) Shenyang Yaoke Daxue Xuebao, 28, pp. 152-156. , through chem. abst CD; Zou, H., Jiang, X., Gao, S., (2005) Dier Junyi Daxue Xuebao Bianjibu, 26, pp. 448-449. , through chem. abst CD; Zheng, Z., Chen, Y., Du, Y., (2003) Zhongguo Xinyao Zazhishe, 12, pp. 1022-1023. , through chem. abst CD; Sarkar, A.K., Ghosh, D., Dhiman, H., Sarkar, P., Gupta, B., Dastidar, S.G., Pal, T.K., (2012) J. Pharm. Biomed. Anal, 71, pp. 144-147; Tong, A., Deng, Z., (2001) Zhongguo Shenghua Yaowu Zazhi Bianjibu, 22, pp. 31-32. , through chem. abst CD; Zhang, W., Zhang, P., Yang, H., (2000) Yaowu Fenxi Zazhi Bianji, 20, pp. 394-396. , through chem. abst CD; Qiu, W., Wang, W., (1985) Zhongguo Yiyao Gongye Zazhi, 16, pp. 71-73; Hong, L., Chu, G., Zhao, B., (1985) Yiyao Gongye, 16, pp. 17-18. , through chem. abst CD; Ganduri, R.B., Peddareddigari, J.R., Dasari, N.R., Saiempu, R.K., (2011) Int. J. Pharm. Tech. Res, 2, pp. 427-433; (2004) United States Pharmacopoeia Commission, , United States Pharmacopeia-National Formulary, United States Pharmacopeial Inc; (2005) International Conference on Harmonization, Geneva, , ICH Validation of Analytical Procedures: Text and Methodology Q2(Rl | |
dcterms.source | Scopus |